Be sure to take advantage of these opportunities at the MD&M East conference and exposition in New York City June 9–11, 2015.

Jamie Hartford

New York City will again play host to the best and brightest minds in medtech when the industry gathers at the Jacob K. Javits Convention Center June 9–11, 2015, for the MD&M East conference and exposition. This three-day interactive event will feature live demonstrations, education programs, and other opportunities you won’t want to miss. Here are a few things we recommend checking out.

Keynotes from Industry Leaders

Anchoring this year’s...

April 21st, 2015
0

Medical device companies can increase efficiency by tightening up their risk management practices.

Jamie Hartford

Efficiency is the name of the game for medical device companies today, and one way for manufacturers to get their products to market faster and at lower cost is to take a close look a their risk management practices.

“Addressing risk management deficiencies is a low-hanging fruit that yields positive results across the board,” says David Amor, managing partner at Medgineering, a Minneapolis-based firm providing remote quality systems, regulatory, remediation, and compliance consulting.

That’s because risk management pervades nearly every step of medical device manufacturing.

...
April 21st, 2015
0

A bad user interface can turn an EMR/EHR into a minefield of medical errors and inefficiency.

Jen Lau

“Hold on, let me get my reading glasses.” I sat there wheezing.

The nurse was painstakingly trying to enter my basic symptoms on a tablet while I was sitting in the urgent care exam room for what turned out to be acute bronchitis. She had to squint at the minuscule lists and tabs to find and select each symptom, repeatedly stabbing at the small checkboxes with her stylus because of the parallax of the resistive display. This was a computer display interface slapped on a touchscreen. The technology was meant to make it easier on provider and patient, but it just made things more difficult and inefficient.

...
April 20th, 2015
1

Recent media coverage of adverse events related to morcellators and duodenoscopes exposes the incompetence of FDA's Center for Devices and Radiological Health.

Jim Dickinson

With growing frequency, it seems, mass media reporting on FDA’s handling of medical device postmarket safety issues portrays galloping ineptitude on the part of this international “gold standard” agency’s weakest component, the Center for Devices and Radiological Health (CDRH).

We had just absorbed the news of the 510(k)-damning laparoscopic power morcellator’s postmarket capacity to spread cancer throughout the bodies of one in 350 women undergoing hysterectomies with morcellation. Almost immediately after this news, we were confronted with outbreaks of even more lethal bacterial...

April 20th, 2015
0

A cardiologist and electrophysiologist familiar with Boston Scientific's novel products bets one has a very bright future ahead. 

Arundhati Parmar

Boston Scientific had a great 2014, and many Wall Street analysts have high hopes for the company this year given the slate of new and novel products that the Massachusetts device maker is introducing.

Two of those novel products are the S-ICD or the percutaneous ICD that has no leads in the heart, often considered the weakest link in an implantable cardioverter defibrillator, and the Watchman Left Atrial Appendage closure device.

One physician, however, believes that while the latter has huge potential for growth because it...

April 16th, 2015
0

IBM is entering healthcare by leveraging its Big Data capabilities and cloud platform, and partnering with Apple, J&J and Medtronic. Why is the partnership notable?

Arundhati Parmar

By now, you already know the basic announcement from International Business Machines.

The technology giant is formally entering the healthcare market by launching the Watson Health Cloud, a secure and open platform for physicians, researchers, insurers and companies engaged in creating health and wellness solutions. It is also leveraging its Big Data analytics capabilities and partnering with medtech heavyweights like Johnson & Johnson and Medtronic, as well as Apple in...

April 15th, 2015
0

A cartoon usurps Aesop's tortoise and the hare tale to humorously capture the difference between traditional medtech firms and their upstart wearable devices brethren. 

Arundhati Parmar

A healthcare futurist a few years ago declared that Silicon Valley has set its sights on the medtech industry.

They see it as slow and ripe for disruption. He wasn't wrong given how nontraditional companies like Apple, Google and Samsung are innovating in healthcare.

Perhaps the best description of the divide between the latest hot new healthcare trend - wearables - and medtech if we are to separate the sides into two distinct, battling camps comes from this cartoon...

April 14th, 2015
0

In J&J's quarterly earnings call, CEO Dominic Caruso expounds on the conglomerate's approach to acquisitions. 

Arundhati Parmar

Just over a month ago, Financial Times reported that Johnson & Johnson was nearing a deal for Pharmacyclics, a cancer-drug maker. That was before AbbVie apparently swooped in and beat the New Jersey conglomerate by pocketing the company for $21 billion. 

The last mega deal Johnson & Johnson did was back in 2012 when it bought orthopedics company Synthes for $19.7 billion.

In its first-quarter conference call with analysts Monday, Johnson & Johnson's CEO - Dominic Caruso - was asked if the company had an appetite for large acquisitions...

April 14th, 2015
0

Silicon Valley

As the center of the tech universe, Silicon Valley is a draw for big dreamers with STEM degrees—biomedical engineers among them. The San Jose-Sunnyvale-Santa Clara area is home to the fourth-highest concentration of biomedical engineering jobs and offers the second-highest annual mean wage in the country.

Biomedical Engineer Employment: 820

Employment per 1000 Jobs: 0.84

Annual Mean Wage: $117,620 (28% higher than the national mean)

...

April 14th, 2015
0